MCID: HRD054
MIFTS: 36

Hereditary Neuropathy with Liability to Pressure Palsy

Categories: Rare diseases, Neuronal diseases, Genetic diseases

Aliases & Classifications for Hereditary Neuropathy with Liability to Pressure Palsy

MalaCards integrated aliases for Hereditary Neuropathy with Liability to Pressure Palsy:

Name: Hereditary Neuropathy with Liability to Pressure Palsy 53
Hereditary Liability to Pressure Palsies 73
Polyneuropathy, Familial Recurrent 53
Tomaculous Neuropathy 53
Hnpp 53

Classifications:



Summaries for Hereditary Neuropathy with Liability to Pressure Palsy

NIH Rare Diseases : 53 Hereditary neuropathy with liability to pressure palsy (HNPP) is a disorder that affects peripheral nerves. This condition causes recurrent episodes of numbness, tingling, and/or loss of muscle function (palsy). An episode can last from several minutes to several months, but recovery is usually complete. Repeated incidents, however, can cause permanent muscle weakness or loss of sensation. The most common problem sites involve nerves in wrists, elbows, and knees. Symptoms usually begin during adolescence or early adulthood but may develop anytime from childhood to late adulthood. Symptoms vary in severity; many people never realize they have the disorder, while some people experience prolonged disability. This condition is caused by the loss of one copy of the PMP22 gene or alterations within the gene. It is inherited in an autosomal dominant  manner.

MalaCards based summary : Hereditary Neuropathy with Liability to Pressure Palsy, also known as hereditary liability to pressure palsies, is related to neuropathy, hereditary, with liability to pressure palsies and hereditary neuropathies. An important gene associated with Hereditary Neuropathy with Liability to Pressure Palsy is PMP22 (Peripheral Myelin Protein 22), and among its related pathways/superpathways is Neural Crest Differentiation. The drugs Lidocaine and Bupivacaine have been mentioned in the context of this disorder. Affiliated tissues include testes, skin and liver.

Wikipedia : 76 Hereditary Neuropathy with Liability to Pressure Palsy (HNPP) is a peripheral neuropathy, a disorder of... more...

Related Diseases for Hereditary Neuropathy with Liability to Pressure Palsy

Diseases related to Hereditary Neuropathy with Liability to Pressure Palsy via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 49)
# Related Disease Score Top Affiliating Genes
1 neuropathy, hereditary, with liability to pressure palsies 32.5 LITAF MPZ PMP22
2 hereditary neuropathies 31.1 MPZ PMP22
3 neuropathy 30.1 MPZ PMP22
4 foot drop 29.8 MPZ PMP22
5 tooth disease 29.5 LITAF MPZ PMP22
6 chronic inflammatory demyelinating polyradiculoneuropathy 29.4 MPZ PMP22
7 charcot-marie-tooth disease 29.4 LITAF MPZ PMP22
8 polyradiculoneuropathy 29.3 MPZ PMP22
9 pelizaeus-merzbacher disease 29.3 MPZ PMP22
10 polyneuropathy 29.3 MPZ PMP22
11 peripheral nervous system disease 29.2 MPZ PMP22
12 mononeuropathy of the median nerve, mild 11.6
13 plexopathy 10.4
14 carpal tunnel syndrome 10.3
15 amyotrophy, hereditary neuralgic 10.3
16 amyotrophic neuralgia 10.3
17 amyotrophic lateral sclerosis 1 10.2
18 lateral sclerosis 10.2
19 oculopharyngeal muscular dystrophy 10.1
20 diabetes mellitus 10.1
21 sciatic neuropathy 10.1
22 mononeuropathy 10.1
23 bell's palsy 10.1
24 brachial plexus neuropathy 10.1
25 demyelinating polyneuropathy 10.1
26 muscular atrophy 10.1
27 influenza 10.1
28 muscular dystrophy 10.1
29 fibromyalgia 10.1
30 myoclonus 10.1
31 congenital hypomyelination neuropathy 9.7 MPZ PMP22
32 charcot-marie-tooth neuropathy type 1 9.6 MPZ PMP22
33 roussy-levy hereditary areflexic dystasia 9.6 MPZ PMP22
34 charcot-marie-tooth disease, demyelinating, type 1f 9.6 MPZ PMP22
35 charcot-marie-tooth disease, demyelinating, type 1b 9.6 MPZ PMP22
36 charcot-marie-tooth disease, axonal, type 2b 9.6 MPZ PMP22
37 motor peripheral neuropathy 9.6 MPZ PMP22
38 charcot-marie-tooth disease, demyelinating, type 1a 9.6 MPZ PMP22
39 charcot-marie-tooth disease, demyelinating, type 1d 9.5 MPZ PMP22
40 guillain-barre syndrome 9.5 MPZ PMP22
41 neuritis 9.4 MPZ PMP22
42 diabetic neuropathy 9.4 MPZ PMP22
43 neuromuscular disease 9.3 MPZ PMP22
44 charcot-marie-tooth disease, axonal, type 2e 9.1 MPZ PMP22
45 charcot-marie-tooth disease, demyelinating, type 1c 9.1 LITAF MPZ PMP22
46 charcot-marie-tooth disease and deafness 9.1 LITAF MPZ PMP22
47 hypertrophic neuropathy of dejerine-sottas 9.1 LITAF MPZ PMP22
48 sensory peripheral neuropathy 9.1 LITAF MPZ PMP22
49 neuropathy, congenital hypomyelinating or amyelinating, autosomal recessive 9.0 LITAF MPZ PMP22

Graphical network of the top 20 diseases related to Hereditary Neuropathy with Liability to Pressure Palsy:



Diseases related to Hereditary Neuropathy with Liability to Pressure Palsy

Symptoms & Phenotypes for Hereditary Neuropathy with Liability to Pressure Palsy

Drugs & Therapeutics for Hereditary Neuropathy with Liability to Pressure Palsy

Drugs for Hereditary Neuropathy with Liability to Pressure Palsy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 202)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 137-58-6 3676
2
Bupivacaine Approved, Investigational Phase 4,Not Applicable 2180-92-9, 38396-39-3 2474
3
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 50-24-8 5755
4
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 83-43-2 6741
5
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
6
Gabapentin Approved, Investigational Phase 4,Phase 3 60142-96-3 3446
7
Triamcinolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 124-94-7 31307
8
Acetaminophen Approved Phase 4,Phase 2 103-90-2 1983
9
Ropivacaine Approved Phase 4,Not Applicable 84057-95-4 71273 175805
10
Betamethasone Approved, Vet_approved Phase 4,Phase 3 378-44-9 9782
11
gamma-Aminobutyric acid Approved, Investigational Phase 4,Phase 3 56-12-2 119
12
Hydrocodone Approved, Illicit Phase 4 125-29-1 5284569
13
Ibuprofen Approved Phase 4,Phase 2 15687-27-1 3672
14
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
15
Benzocaine Approved, Investigational Phase 4 1994-09-7, 94-09-7 2337
16
Oxycodone Approved, Illicit, Investigational Phase 4,Phase 2 76-42-6 5284603
17
Vitamin A Approved, Nutraceutical, Vet_approved Phase 4 11103-57-4, 68-26-8 445354
18
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3 59-30-3 6037
19 tannic acid Approved, Nutraceutical Phase 4
20 Prednisolone acetate Phase 4,Phase 2,Phase 3,Not Applicable
21 Analgesics Phase 4,Phase 3,Phase 2,Not Applicable
22 glucocorticoids Phase 4,Phase 3,Phase 2,Not Applicable
23 Respiratory System Agents Phase 4,Phase 3,Not Applicable
24 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
25 Methylprednisolone acetate Phase 4,Phase 2,Phase 3,Not Applicable
26 Methylprednisolone Hemisuccinate Phase 4,Phase 2,Phase 3,Not Applicable
27 Gastrointestinal Agents Phase 4,Phase 2,Phase 3,Not Applicable
28 Sodium Channel Blockers Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
29 Neuroprotective Agents Phase 4,Phase 2,Phase 3,Not Applicable
30 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
31 Analgesics, Non-Narcotic Phase 4,Phase 2,Not Applicable
32 Anesthetics Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
33 Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
34 Anesthetics, Local Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
35 Tranquilizing Agents Phase 4,Phase 3,Phase 2,Not Applicable
36 Hormones Phase 4,Phase 3,Phase 2,Not Applicable
37 Diuretics, Potassium Sparing Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
38 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
39 Anti-Arrhythmia Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
40 Anti-Asthmatic Agents Phase 4,Phase 3,Not Applicable
41 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
42 Anticonvulsants Phase 4,Phase 3,Not Applicable
43 Prednisolone hemisuccinate Phase 4,Phase 2,Phase 3,Not Applicable
44 Prednisolone phosphate Phase 4,Phase 2,Phase 3,Not Applicable
45 Antiemetics Phase 4,Phase 2,Phase 3,Not Applicable
46 Protective Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
47 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Not Applicable
48 Psychotropic Drugs Phase 4,Phase 3,Phase 2,Not Applicable
49 Antimanic Agents Phase 4,Phase 3,Not Applicable
50 Autonomic Agents Phase 4,Phase 2,Phase 3,Not Applicable

Interventional clinical trials:

(show top 50) (show all 267)
# Name Status NCT ID Phase Drugs
1 Postoperative Alpha Lipoic Acid in the Carpal Tunnel Syndrome: a Randomized Controlled Trial. Completed NCT01895621 Phase 4
2 Local Steroid Injection vs Placebo in Carpal Tunnel Syndrome Completed NCT02652390 Phase 4 Methylprednisolone 80 mg;Methylprednisolone 40 mg
3 Pain Outcomes of Intra-operative IV Tylenol and/or IV Toradol for Carpal Tunnel and Distal Radius Fracture Surgeries Completed NCT02313675 Phase 4 Acetaminophen;Ketorolac Tromethamine;Saline
4 Efficacy Study of Local Steroid Injection and Wrist Splinting for Carpal Tunnel Syndrome Completed NCT02140632 Phase 4
5 Bupivacaine Versus Lidocaine Local Anesthesia Completed NCT01751347 Phase 4 Bupivacaine;Lidocaine
6 Length of Post Operative Dressing After Carpal Tunnel Release Completed NCT01310218 Phase 4
7 A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions Completed NCT00904202 Phase 4 Placebo Capsules + Placebo Patch;Placebo capsules + Lidoderm®;Gabapentin + Placebo;Gabapentin + Lidoderm®;Gabapentin 300 mg capsules 1800 mg/day + placebo patch;Gabapentin 1800 mg/day + Lidoderm patch
8 Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters Completed NCT00678314 Phase 4 Ropivacaine 0.2%;Ropivacaine 0.75%;Normal saline
9 Therapeutic Effects Analysis of Pudendal Nerve Infiltrations After 3 Months, in Patients Suffering of Pudendal Neuralgia Completed NCT00851513 Phase 4 Lidocaine;Depmedrol
10 Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome Completed NCT00277563 Phase 4
11 Narcotic vs. Non-narcotic Pain Study Protocol Recruiting NCT01974609 Phase 4 Narcotic;non-narcotic
12 Non-surgical Treatment of Carpal Tunnel Syndrome: Night Splint Versus Local Corticosteroid Infiltration Active, not recruiting NCT03196817 Phase 4 betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2%
13 Injection Versus Splinting in Carpal Tunnel Syndrome Active, not recruiting NCT02038452 Phase 4 Depo-Medrone
14 Post-operative Analgesia in Elective, Soft-tissue Hand Surgery Enrolling by invitation NCT02029235 Phase 4 Acetaminophen/Hydrocodone;Acetaminophen/Ibuprofen
15 Preoperative Antibiotics for Carpal Tunnel Release Surgery Not yet recruiting NCT03432858 Phase 4 Vancomycin;Cefazolin;Saline Solution
16 Patient Satisfaction With Pain Relief After Ambulatory Hand Surgery Terminated NCT01588158 Phase 4 Acetaminophen;Vicodin
17 Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain Withdrawn NCT02748395 Phase 4 Triamcinolone;Lidocaine
18 Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A) Unknown status NCT01289704 Phase 2, Phase 3
19 Carpal Tunnel Syndrome Release Using PSU Retractor Unknown status NCT01017471 Phase 3
20 High Dose Ascorbic Acid Treatment of CMT1A Completed NCT00484510 Phase 2, Phase 3 Ascorbic acid (Vitamin C);placebo
21 Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome Completed NCT02141035 Phase 2, Phase 3 Acetyl-l-carnitine;placebo
22 Sonographic Examination Cubital Tunnel Release Completed NCT02739945 Phase 3
23 Sonography-guided Steroid Injection for Carpal Tunnel Syndrome Completed NCT02575729 Phase 3 betamethasone
24 Preoperative Gabapentine for Carpal Tunnel Completed NCT01632215 Phase 3 Gabapentine
25 Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia Completed NCT02604186 Phase 2, Phase 3
26 Steroid Injection Treatment of Carpal Tunnel Syndrome Completed NCT00806871 Phase 2, Phase 3 Methylprednisolone 40 mg;Methylprednisolone 80 mg;Sodium chloride
27 Gabapentin for Carpal Tunnel Syndrome Completed NCT00137735 Phase 3 Gabapentin
28 Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid Completed NCT00007020 Phase 3 Cholic Acids
29 Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Recruiting NCT03023540 Phase 3 PXT3003
30 Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity Recruiting NCT03013543 Phase 2, Phase 3 Setmelanotide
31 Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) Active, not recruiting NCT02579759 Phase 3 PXT3003 dose 1;PXT3003 dose 2;placebo
32 Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome Enrolling by invitation NCT03184584 Phase 2, Phase 3 PBI-4050
33 Assessment of the Effectiveness of Ultrasound-guided Acupuncture in the Management of Carpal Tunnel Syndrome Not yet recruiting NCT02870673 Phase 2, Phase 3 SHINCORT;XYLOCAINE
34 Erythropoietin Spinal Cord Compression Randomized Trial Terminated NCT00220675 Phase 2, Phase 3 Erythropoietin infusion
35 NeuroPath Comparative Validation Study Plan Terminated NCT00393549 Phase 3
36 A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures Terminated NCT00209560 Phase 3 fospropofol disodium
37 Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome Terminated NCT00266214 Phase 3 lidocaine patch 5%
38 Carpal Tunnel Syndrome and Static Magnetic Field Therapy Unknown status NCT00521495 Phase 2
39 Carpal Tunnel Syndrome Treated With 830nm Diode Laser Unknown status NCT00514462 Phase 1, Phase 2
40 Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease Completed NCT00541164 Phase 1, Phase 2 Coenzyme Q10
41 Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease Completed NCT02561702 Phase 2 Mexiletine
42 Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A Completed NCT01401257 Phase 2 PXT3003 Low dose;PXT3003 Intermediate Dose;PXT3003 High Dose
43 Ascorbic Acid Treatment in CMT1A Trial (AATIC) Completed NCT00271635 Phase 2 Placebo;ascorbic acid
44 The Treatment of the Median Nerve for the Elimination of the Symptoms Associated With the Carpal Tunnel Syndrome Completed NCT00634738 Phase 1, Phase 2
45 L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1 Completed NCT01733407 Phase 1, Phase 2 L-serine;placebo
46 Comparison of Effect of Anterior Subcutaneous and Submuscular Transposition on Cubital Tunnel Syndrome Completed NCT01109901 Phase 2
47 A Pilot Study to Evaluate the Effectiveness of Ultrasound Guided Looped Thread Carpal Tunnel Release Completed NCT03476486 Phase 2
48 Treatment of Thoracic Outlet Syndrome (TOS) With Botox Completed NCT00444886 Phase 2 Botulinum Toxin Type A injection (BOTOX);Botulinum Toxin Type A injection (BOTOX)
49 Percutaneous Treatment of Carpal Tunnel Syndrome With Scan Completed NCT02514317 Phase 2
50 Fascial Manipulation on the Treatment of Carpal Tunnel Syndrome Completed NCT02495298 Phase 2

Search NIH Clinical Center for Hereditary Neuropathy with Liability to Pressure Palsy

Genetic Tests for Hereditary Neuropathy with Liability to Pressure Palsy

Anatomical Context for Hereditary Neuropathy with Liability to Pressure Palsy

MalaCards organs/tissues related to Hereditary Neuropathy with Liability to Pressure Palsy:

41
Testes, Skin, Liver, Heart, Spinal Cord, Brain

Publications for Hereditary Neuropathy with Liability to Pressure Palsy

Articles related to Hereditary Neuropathy with Liability to Pressure Palsy:

(show top 50) (show all 204)
# Title Authors Year
1
Different nerve ultrasound patterns in charcot-marie-tooth types and hereditary neuropathy with liability to pressure palsies. ( 28802056 )
2018
2
Spinobulbar muscular atrophy combined with atypical hereditary neuropathy with liability to pressure palsy. ( 29137918 )
2018
3
Muscle training-induced bilateral brachial plexopathy in an adolescent with sporadic hereditary neuropathy with liability to pressure palsies. ( 28948078 )
2017
4
Hereditary neuropathy with liability to pressure palsy in patients under 30 years old: Neurophysiological data and proposed electrodiagnostic criteria. ( 28407266 )
2017
5
Intravenous Immunoglobulin in Treatment of Hereditary Neuropathy With Liability to Pressure Palsy. ( 28221308 )
2017
6
Hereditary neuropathy with liability to pressure palsy (HNPP): report of a family with a new point mutation in PMP22 gene. ( 29078790 )
2017
7
Characterisation of pain in people with hereditary neuropathy with liability to pressure palsy. ( 29079893 )
2017
8
Acute Demyelinating Polyneuropathy as Presentation of Hereditary Neuropathy With Liability to Pressure Palsies in a Patient Who Exercised Regularly in the Army. ( 28538254 )
2017
9
Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies. ( 27749933 )
2016
10
Clinical and neurophysiological features of the hereditary neuropathy with liability to pressure palsy due to the 17p11.2 deletion. ( 26982985 )
2016
11
Compression of Root Level in a Patient with Hereditary Neuropathy with Liability to Pressure Palsy Diagnosed by Magnetic Resonance Imaging: A Case Report. ( 27149588 )
2016
12
Hereditary neuropathy with liability to pressure palsy presenting as a bilateral brachial plexopathy. ( 26874568 )
2016
13
[Molecular genetic diagnosis and clinical features of hereditary neuropathy with liability to pressure palsies in Belarusian patients]. ( 26977628 )
2016
14
The broad clinical spectrum of hereditary neuropathy with liability to pressure palsy (HNPP). ( 26982983 )
2016
15
An n-of-one RCT for intravenous immunoglobulin G for inflammation in hereditary neuropathy with liability to pressure palsy (HNPP). ( 26187721 )
2015
16
Mutational analysis of Greek patients with suspected hereditary neuropathy with liability to pressure palsies (HNPP): a 15-year experience. ( 26110377 )
2015
17
Proximal arm weakness is the most common presentation in young Korean soldiers diagnosed as having hereditary neuropathy with liability to pressure palsy (HNPP). ( 26462743 )
2015
18
Ultrasonographic findings in hereditary neuropathy with liability to pressure palsies. ( 25005138 )
2014
19
Hereditary neuropathy with liability to pressure palsies presenting with sciatic neuropathy. ( 25326571 )
2014
20
Clinical, electrophysiological and magnetic resonance findings in a family with hereditary neuropathy with liability to pressure palsies caused by a novel PMP22 mutation. ( 24239057 )
2014
21
Characteristic features of hereditary neuropathy with liability to pressure palsy (HNPP) presenting with brachial plexopathy in soldiers. ( 25175852 )
2014
22
PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies. ( 24646194 )
2014
23
Hereditary Neuropathy with Liability to Pressure Palsy Presenting as an Acute Brachial Plexopathy: A Lover's Palsy. ( 25685136 )
2014
24
Pain in hereditary neuropathy with liability to pressure palsy: An association with fibromyalgia syndrome? ( 25042093 )
2014
25
Axonal dysfunction, dysmyelination, and conduction failure in hereditary neuropathy with liability to pressure palsies. ( 24752454 )
2014
26
Does hereditary neuropathy with liability to pressure palsy predispose to schwannomatosis? ( 25324890 )
2014
27
Sonographic evaluation of the peripheral nerves in hereditary neuropathy with liability to pressure palsies: a case report. ( 24639934 )
2014
28
Overlap Phenotype between CMT1A and Hereditary Neuropathy with Liability to Pressure Palsies Caused by the Novel Small In-frame Deletion c.407_418del12 in PMP22 Gene. ( 25265422 )
2014
29
Clinical, electrophysiological, and molecular findings in early onset hereditary neuropathy with liability to pressure palsy. ( 24668782 )
2014
30
Partial Gene Deletions of PMP22 Causing Hereditary Neuropathy with Liability to Pressure Palsies. ( 25506001 )
2014
31
Hereditary neuropathy with liability to pressure palsy: a recurrent and bilateral foot drop case report. ( 24251057 )
2013
32
Hereditary neuropathy with liability to pressure palsy: fulminant radicular dysfunction during anterolateral lumbar interbody fusion. ( 23881104 )
2013
33
Comments on 'hereditary neuropathy with liability to pressure palsy: an investigation in a rare and large chinese family'. ( 24192759 )
2013
34
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated to hereditary neuropathy with liability to pressure palsies (HNPP) and revealed after influenza AH1N1 vaccination. ( 24146347 )
2013
35
Hereditary Neuropathy with Liability to Pressure Palsy: global neuropathy after tourniquet use. ( 24080438 )
2013
36
Bell's palsy and hereditary neuropathy with liability to pressure palsy (HNPP): is there a common genetic background? ( 23635862 )
2013
37
Hereditary neuropathy with liability to pressure palsy: two cases of difficult diagnosis. ( 23965407 )
2013
38
A novel small deletion in PMP22 causes a mild hereditary neuropathy with liability to pressure palsies phenotype. ( 22190321 )
2012
39
Sonographic and electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. ( 23279340 )
2012
40
Hereditary neuropathy with liability to pressure palsies occurring during military training. ( 22545374 )
2012
41
Hereditary neuropathy with liability to pressure palsies. Diagnosis in the first family (1947) confirmed. ( 23279343 )
2012
42
Rapid genetic screening of Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies patients. ( 25337104 )
2012
43
Two cases of elderly-onset hereditary neuropathy with liability to pressure palsy manifesting bilateral peroneal nerve palsies. ( 23185166 )
2012
44
Massive indoor cycling-induced rhabdomyolysis in a patient with hereditary neuropathy with liability to pressure palsy. ( 23240383 )
2012
45
Hereditary neuropathy with liability to pressure palsy combined with suspected schwannomas of the peroneal and radial nerves. ( 22037956 )
2012
46
Sonographic features in hereditary neuropathy with liability to pressure palsies. ( 22581553 )
2012
47
Beneficial use of steroids in hereditary neuropathy with liability to pressure palsy. ( 22098098 )
2012
48
Hereditary neuropathy with liability to pressure palsy: a brief review with a case report. ( 22023293 )
2012
49
Hereditary neuropathy with liability to pressure palsy presenting with hand drop in a young child. ( 22953141 )
2012
50
Hereditary neuropathy with liability to pressure palsy: an investigation in a rare and large Chinese family. ( 23147806 )
2012

Variations for Hereditary Neuropathy with Liability to Pressure Palsy

Copy number variations for Hereditary Neuropathy with Liability to Pressure Palsy from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 106962 17 10700000 16000000 Copy number Hereditary neuropathy with liability to pressure palsy

Expression for Hereditary Neuropathy with Liability to Pressure Palsy

Search GEO for disease gene expression data for Hereditary Neuropathy with Liability to Pressure Palsy.

Pathways for Hereditary Neuropathy with Liability to Pressure Palsy

Pathways related to Hereditary Neuropathy with Liability to Pressure Palsy according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.63 MPZ PMP22

GO Terms for Hereditary Neuropathy with Liability to Pressure Palsy

Cellular components related to Hereditary Neuropathy with Liability to Pressure Palsy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 lysosome GO:0005764 8.62 LITAF MPZ

Biological processes related to Hereditary Neuropathy with Liability to Pressure Palsy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 chemical synaptic transmission GO:0007268 8.96 MPZ PMP22
2 myelination GO:0042552 8.62 MPZ PMP22

Sources for Hereditary Neuropathy with Liability to Pressure Palsy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....